查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1481289

辐射剂量管理市场 - 按产品和服务、模式、应用、部署模式、收入模式、最终用途 - 2024 年 - 2032 年全球预测

Radiation Dose Management Market - By Product & Services, Modality, Application, Mode of Deployment, Revenue Model, End-use - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在先进医学影像技术日益普及的推动下，辐射剂量管理市场规模从 2024 年到 2032 年将以 13.2% 的复合年增长率成长。 CT、X 光和透视检查程序在诊断和介入环境中的广泛使用导致了更高的辐射暴露风险。为此，医疗保健提供者正在转向辐射剂量管理解决方案来监控和优化剂量，以确保患者安全。对准确剂量追踪、即时监测和优化工具的需求正在不断增加，特别是随着需要频繁成像的慢性疾病的盛行率不断上升。

此外，医疗保健技术公司和研究机构之间的合作正在推动剂量监测和优化解决方案的创新。例如，2023 年11 月，新型医疗保健解决方案的领先开发商Qaelum NV 与全球健康技术先驱飞利浦建立了战略合作伙伴关係，重新定义医学成像中的辐射剂量控制，以提高患者安全并简化医疗保健运营。此类尖端产品正在满足医疗保健提供者对辐射安全和效率不断变化的需求，进一步促进市场成长。

辐射剂量管理产业分为产品和服务、模式、应用、部署模式、收入模式、最终用途和区域。

根据产品和服务，解决方案领域的市场规模进一步细分为独立和集成，预计 2024 年至 2032 年复合年增长率将达到 13%。医疗机构越来越多地采用提供即时监测、剂量追踪和优化工具的综合解决方案，以确保患者安全。这些解决方案还使医疗保健提供者能够有效管理辐射剂量，同时减少患者不必要的暴露和潜在风险。对高级分析、剂量报告和工作流程整合功能的需求将推动该细分市场的成长。

在应用方面，心臟病领域的辐射剂量管理产业在2023年需求旺盛，预计2024年至2032年将达到13.7%的成长率。心血管疾病的日益普及和介入性心臟病学手术的日益普及也增加了对辐射剂量管理解决方案的需求。此外，对病患安全和监管合规性的日益关注促使医疗机构为心臟科部署辐射剂量管理解决方案。

从地区来看，由于先进医学影像技术的日益采用、辐射安全意识的提高以及医疗机构数量的增加，到 2032 年，亚太地区辐射剂量管理行业的复合年增长率将达到 14.1%。由于高度重视病患安全和监管合规性，该地区的医疗保健提供者正在投资辐射剂量管理解决方案。此外，需要影像程序的慢性疾病盛行率不断上升，以及最大限度地减少辐射暴露的强烈需求将增强该地区的行业前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 医学影像技术的技术进步
      • 对医学影像模式的需求不断增长
    • 产业陷阱与挑战
      • 实施辐射剂量管理解决方案的成本高昂
      • 缺乏标准化
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势
  • 缺口分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品和服务划分，2018 年 - 2032 年

  • 主要趋势
  • 解决方案
    • 独立解决方案
    • 综合解决方案
  • 服务
    • 实施和整合服务
    • 支援和维护服务
    • 咨询服务
    • 教育及培训服务
    • 辐射剂量管理

第 6 章：市场估计与预测：按模式，2018 - 2032 年

  • 主要趋势
  • CT检查
  • 透视和介入成像
  • 射线照相
  • 乳房X光检查
  • 核子医学

第 7 章：市场估计与预测：按应用划分，2018 年 - 2032 年

  • 主要趋势
  • 肿瘤学
  • 心臟病学
  • 牙科
  • 骨科
  • 其他应用

第 8 章：市场估计与预测：按部署模式，2018 - 2032 年

  • 主要趋势
  • 本地
  • 基于云端
  • 基于网路

第 9 章：市场估计与预测：按收入模式，2018 - 2032

  • 主要趋势
  • 基于订阅的收入模式
  • 按使用付费的收入模式

第 10 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 诊断和影像中心
  • 其他最终用户

第 11 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 12 章：公司简介

  • Agfa-Gevaert Group
  • Bayer AG
  • Bracco
  • Canon Medical Systems Corporation
  • Ge HealthCare Technologies Inc.
  • Guerbet
  • INFINITT Healthcare Co., Ltd.
  • Koninklijke Philips N.V.
  • Medsquare S.A.S.
  • PACSHealth, LLC.
  • Sectra AB
  • Siemens Healthineers AG
简介目录
Product Code: 8367

Radiation Dose Management Market size is poised to grow at 13.2% CAGR from 2024-2032 driven by the increasing adoption of advanced medical imaging technologies. The widespread use of CT, X-ray, and fluoroscopy procedures in diagnostic and interventional settings has led to higher radiation exposure risks. To that end, healthcare providers are turning to radiation dose management solutions to monitor and optimize doses for ensuring patient safety. The demand for accurate dose tracking, real-time monitoring, and optimization tools is rising, particularly with the growing prevalence of chronic diseases requiring frequent imaging.

Furthermore, collaborations between healthcare technology companies and research institutions are driving innovations in dose monitoring and optimization solutions. For instance, in November 2023, Qaelum NV, a leading developer of novel healthcare solutions, and Philips, a global pioneer in health technology, formed a strategic partnership to redefine radiation dose control in medical imaging to improve patient safety and streamline healthcare operations. Such cutting-edge products are meeting the evolving needs of healthcare providers for radiation safety and efficiency, further contributing to the market growth.

The radiation dose management industry is segmented into products & services, modality, applications, mode of deployment, revenue model, end-use, and region.

Based on products & services, the market size from the solutions segment, further sub-segmented into standalone and integrated, is anticipated to garner 13% CAGR from 2024-2032. Healthcare facilities are increasingly adopting comprehensive solutions that offer real-time monitoring, dose tracking, and optimization tools to ensure patient safety. These solutions also provide healthcare providers with the ability to efficiently manage radiation doses while reducing unnecessary exposure and potential risks to patients. The demand for advanced analytics, dose reporting, and workflow integration capabilities will boost the segment growth.

In terms of application, the radiation dose management industry from the cardiology segment witnessed high demand in 2023 and is estimated to attain a 13.7% growth rate between 2024 and 2032. Cardiac procedures often involve radiation exposure, necessitating precise management to ensure patient safety. The increasing prevalence of cardiovascular diseases and the rising adoption of interventional cardiology procedures are also contributing to the demand for radiation dose management solutions. Additionally, the increasing focus on patient safety and regulatory compliance has spurred healthcare facilities to deploy radiation dose management solutions for cardiology departments.

Regionally, the Asia Pacific radiation dose management industry is set to exhibit 14.1% CAGR through 2032 attributed to the increasing adoption of advanced medical imaging technologies, rising awareness of radiation safety, and the growing number of healthcare facilities. With the strong focus on patient safety and regulatory compliance, healthcare providers in the region are investing in radiation dose management solutions. Additionally, the rising prevalence of chronic diseases requiring imaging procedures and the strong need to minimize radiation exposure will augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in medical imaging technology
      • 3.2.1.3 Growing demand for medical imaging modalities
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of implementing radiation dose management solutions
      • 3.2.2.2 Lack of standardization
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Solutions
    • 5.2.1 Standalone solutions
    • 5.2.2 Integrated solutions
  • 5.3 Services
    • 5.3.1 Implementation & integration services
    • 5.3.2 Support & maintenance services
    • 5.3.3 Consulting services
    • 5.3.4 Education & training services
    • 5.3.5 Radiation dose management

Chapter 6 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Computed tomography
  • 6.3 Fluoroscopy & interventional imaging
  • 6.4 Radiography
  • 6.5 Mammography
  • 6.6 Nuclear medicine

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Oncology
  • 7.3 Cardiology
  • 7.4 Dental
  • 7.5 Orthopedic
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Mode of Deployment, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 On-premises
  • 8.3 Cloud-based
  • 8.4 Web-based

Chapter 9 Market Estimates and Forecast, By Revenue Model, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Subscription-based revenue model
  • 9.3 Pay-per-use revenue model

Chapter 10 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Hospitals
  • 10.3 Ambulatory surgical centers
  • 10.4 Diagnostic and imaging centers
  • 10.5 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Agfa-Gevaert Group
  • 12.2 Bayer AG
  • 12.3 Bracco
  • 12.4 Canon Medical Systems Corporation
  • 12.5 Ge HealthCare Technologies Inc.
  • 12.6 Guerbet
  • 12.7 INFINITT Healthcare Co., Ltd.
  • 12.8 Koninklijke Philips N.V.
  • 12.9 Medsquare S.A.S.
  • 12.10 PACSHealth, LLC.
  • 12.11 Sectra AB
  • 12.12 Siemens Healthineers AG